![DISRUPTLogo-MedHorizontal[1].png](https://static.wixstatic.com/media/1ad237_0694e719fff24e1b99901c9a23a001c1~mv2.png/v1/fill/w_130,h_50,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/DISRUPTLogo-MedHorizontal%5B1%5D.png)
Diversity & IncluSion in Research Underpinning Prevention & Therapy Trials
![DISRUPTLogo-MedHorizontal[1].png](https://static.wixstatic.com/media/1ad237_0694e719fff24e1b99901c9a23a001c1~mv2.png/v1/fill/w_500,h_200,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/DISRUPTLogo-MedHorizontal%5B1%5D.png)
Diversity & Inclusion in Scientific Research Underpinning Prevention & Therapy Trials
Leadership
DISRUPT brings together multidisciplinary teams from four New York City institutions, Mount Sinai’s Tisch Cancer Institute (TCI), Columbia’s Herbert Irving Comprehensive Cancer Center (HICCC), Montefiore Einstein Cancer Center (MECC) and The City College of New York (CCNY).
These cancer centers are charged with reducing cancer disparities that affect approximately two million people residing in some of the most diverse and underserved communities in the United States.
Dr. Nina Bickell
MD, MPH
Project Leader
Nina Bickell, MD, MPH, has spent the past 20 years focusing on underlying reasons for disparities in the quality of cancer care many BIPOC patients get and designing different approaches to improve their cancer care. Dr. Bickell is a member of the senior leadership team at The Tisch Cancer Institute (TCI).
Dr. David Lounsbury
PhD
Co-investigator
David Lounsbury is an Associate Professor of Epidemiology and Population Health and Associate Director of Patient-Centered Outcomes Research Training at the Albert Einstein College of Medicine. As a community psychologist and a systems scientist, David designs and conducts research that strives to strengthen community partnerships to improve the way health care works in the Bronx and beyond.
Mary Beth Terry
Ph.D
Co-investigator
Mary Beth Terry, PhD, focuses her research on environmental modifiers of cancer risk. She is the Director of Community Outreach and Engagement with the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center. She has spent over 20 years leading studies of cancer risk reduction in local communities and around the world.
Dr. Grace Hillyer
EdD
Co-investigator
Dr. Hillyer’s expertise lies in the applied use of behavioral theory to investigate multilevel
psychological, social, and cultural factors impacting health behavior among underrepresented
and underserved populations and the application of mixed research methodology to construct
and implement tailored educational interventions.